Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Eczema: early-phase trial registry
13 of 30 indexed Eczema trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #519 of 28,707 conditions by registered trial count.
30 US clinical trials · 13 currently recruiting · #519 of 28,707 conditions by registered trial count
Eczema: 30 US clinical trials tracked, 13 recruiting.
Eczema is the subject of 30 registered US clinical trials on ClinicalTrials.gov, 13 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most active sponsor is Seeding, running 2 of these trials.
Enrollment posture brief
Registry condition eczema
OPEN 13 | RECR 43% | LATE 6 | EARLY 11 | RANK #519 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Bronchopulmonary Dysplasia (43% recruiting · 30 trials)
Eczema lists 13 open slots (43% of 30 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Eczema on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Eczema is recruiting above its size-band peers.
13 of 30 indexed trials (43.3%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Eczema trials is spread across many organizations.
Seeding accounts for 2 of 30 trials (6.7%). 29 distinct sponsors appear on at least one study for this condition label.
-
Typical Eczema enrolment sits around 125 participants.
Median target enrolment is 125 among the 30 trials that report a genuine target (sentinel values excluded). 12 of those (40%) plan for fewer than 100 participants.
-
Eczema research is mostly interventional.
22 interventional and 8 observational studies make up this index (73.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
30 total, page 1 of 1
Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
University of California, San Diego
NCT05938478
Studies of Skin Microbes in Healthy People and in People With Skin Conditions
National Human Genome Research Institute (NHGRI)
NCT00605878
Flourish: Exploring the Early Infant Gut Microbiome
Seeding
NCT07333482
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Inmagene
NCT07037901
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
University of Pittsburgh
NCT00177268
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Corvus Pharmaceuticals
NCT07441395
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Pfizer
NCT06807268
Effects of Treatments on Atopic Dermatitis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT01631617
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics
NCT07453602
Cardamom and Topical Roseomonas in Atopic Dermatitis
National Institute of Allergy and Infectious Diseases (NIAID)
NCT06096857
A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis)
Turn Therapeutics
NCT07355075
ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
Aclaris Therapeutics
NCT07011706
Sodium in the Skin and Atopic Dermatitis
University of California, San Francisco
NCT06998446
Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis
Northwestern University
NCT01782703
Seal, Stopping Eczema and Allergy Study
Kari Nadeau, MD, PhD
NCT03742414
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Eli Lilly and Company
NCT05559359
Infant Restore: Efficacy of Microbiome Analysis and Education
Seeding
NCT06424691
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Stiefel, a GSK Company
NCT00817063
Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis
University of Southern California
NCT03981926
Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)
Nucryst Pharmaceuticals
NCT00076375
A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
Janssen Research & Development
NCT04021862
Joovvin' for Your Skin Health Study
ProofPilot
NCT04471896
Oral Bacteria and Allergic Disease in Children
National Institute of Environmental Health Sciences (NIEHS)
NCT00438646
Sleep, Circadian Rhythm & Skin Health
University Hospitals Cleveland Medical Center
NCT02457000
Response of Children With Atopic Dermatitis (Eczema) to Eucrisa
Ann & Robert H Lurie Children's Hospital of Chicago
NCT04023084
Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis
Frankel, Amylynne, M.D.
NCT01202149
Bone Health in Patients With Atopic Dermatitis
Mayo Clinic
NCT03800004
A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis
AOBiome
NCT03775434
Steroid-reducing Effects of Crisaborole
Johns Hopkins University
NCT03832010
Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy
Rockefeller University
NCT01149759
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 9 |
| Phase 3 | 3 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Eczema records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Eczema trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Eczema page
30 registered trials, 13 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 13 Eczema trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Seeding sponsors the most Eczema trials on record, review their full trial history before evaluating a specific study. See Seeding's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Eczema condition card totals 30 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.